Fundraising FoxAccuitis
Atlanta, US · 2 known investors
Find your way into Accuitis
Sign up to see every warm intro you have to Accuitis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Accuitis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Accuitis is developing a lead drug compound that restores mitochondrial SIRT3 expression to recover healthy cellular function, targeting neurodegenerative diseases including Alzheimer's, Parkinson's, and methamphetamine addiction. Its work is in preclinical research and development.
Investors · 2
Frequently asked questions
- What does Accuitis do?
- Accuitis is developing a lead drug compound that restores mitochondrial SIRT3 expression to recover healthy cellular function, targeting neurodegenerative diseases including Alzheimer's, Parkinson's, and methamphetamine addiction. Its work is in preclinical research and development.
- Who are Accuitis's investors?
- Accuitis's investors include Atlanta Technology Angels, GRA Venture.
- Where is Accuitis headquartered?
- Accuitis is headquartered in Atlanta, US.